SCHEMBL4852487

SCHEMBL4852487

CCc1nc(-c2ccccc2)cc(=O)n1CC(=O)Nc1ccc(OC(C)(C)C(=O)O)cc1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KAT2B Q92831 5/20 0.47
KDM4E B2RXH2 3/20 0.46
ALDH1A1 P00352 3/20 0.46
MAPT P10636 3/20 0.46
MEN1 O00255 2/20 0.46
HPGD P15428 2/20 0.46
KMT2A Q03164 2/20 0.46
TP53 P04637 1/20 0.44
PPARG P37231 4/20 0.44
PPARA Q07869 3/20 0.44
HSD17B10 Q99714 1/20 0.41
LMNA P02545 2/20 0.40
THRB P10828 1/20 0.40
PPARD Q03181 1/20 0.40
ADORA3 P0DMS8 1/20 0.39
ADORA2A P29274 1/20 0.39
ADORA2B P29275 1/20 0.39
ADORA1 P30542 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4856384 0.91 KAT2B (0.45) KAT2BKDM4EALDH1A1MAPTMEN1
SCHEMBL4859287 0.82 PPARG (0.48) PPARGPPARAPPARD
SCHEMBL4853835 0.80 PPARA (0.46) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL14263880 0.77 TP53 (0.42) KAT2BKDM4EALDH1A1MAPTMEN1
SCHEMBL4855575 0.77 TP53 (0.44) KAT2BKDM4EALDH1A1MAPTMEN1
SCHEMBL4852508 0.76 ALDH1A1 (0.44) KAT2BKDM4EALDH1A1MAPTMEN1
SCHEMBL14263926 0.76 LMNA (0.43) KAT2BKDM4EALDH1A1MAPTMEN1
SCHEMBL4850739 0.75 GSK3B (0.47) KDM4EALDH1A1MAPTMEN1HPGD
SCHEMBL4858080 0.74 GSK3B (0.38) KDM4EALDH1A1MAPTMEN1HPGD
SCHEMBL4851012 0.74 PPARG (0.41) HPGDPPARGPPARAPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7348334-B2 Monocyclic derivatives of aryl alkanoic acids and their use in medicine: process for their preparation and pharmaceutical compositions containing them DR. REDDY'S LABORATORIES LIMITED (IN) 2008-03-25 US claimed
US-20030013729-A1 New monocyclic derivatives of aryl alkanoic acids and their use in medicine: process for their preparation and pharmaceutical compositions containing them DR. REDDY'S LABORATORIES LTD. 2003-01-16 US claimed
US-7348334-B2 Monocyclic derivatives of aryl alkanoic acids and their use in medicine: process for their preparation and pharmaceutical compositions containing them DR. REDDY'S LABORATORIES LIMITED (IN) 2008-03-25 US disclosed
US-7348334-B2 Monocyclic derivatives of aryl alkanoic acids and their use in medicine: process for their preparation and pharmaceutical compositions containing them DR. REDDY'S LABORATORIES LIMITED (IN) 2008-03-25 US disclosed
US-20030013729-A1 New monocyclic derivatives of aryl alkanoic acids and their use in medicine: process for their preparation and pharmaceutical compositions containing them DR. REDDY'S LABORATORIES LTD. 2003-01-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030013729-A1 New monocyclic derivatives of aryl alkanoic acids and their use in medicine: process for their preparation and pharmaceutical compositions containing them GPR119, FFAR1, FFAR3 KAT2B 2039/4885KDM4E 1929/4885ALDH1A1 308/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.